- Company
- About Us
- Management Team
- Board of Directors
- Collaborations
- Careers
- Contact Us
- Science
- Onco-Metabolism Platform
- Therapeutic Areas
- Publications
- Programs
- Pipeline
- Glutaminase Inhibitor Telaglenastat
- Arginase Inhibitor INCB001158
- Arginase Inhibitor
CB-280 - CD73 Inhibitor
CB-708 - Clinical Trials
- Clinical Trials Overview
- Expanded Access
- Media & Investors
- Corporate Profile
- Press Releases
- Event & Presentations
- Stock Information
- Financial Information
- Overview
- SEC Filings
- Ownership Summary
- Analyst Coverage
- Corporate Governance
- Highlights
- Board of Directors
- Management Team
- Committee Composition
- Shareholder Services
Company
Contact Us
Calithera Biosciences, Inc.
343 Oyster Point Blvd, Suite 200
South San Francisco, CA 94080
+1 650 870 1000Department Representatives
Investor & Media Contact
Jennifer McNealey
Vice President, Investor Relations
and StrategyBusiness Development Contact
Matt Gross
Director of Business DevelopmentScientific Collaborations Contact
Marina Gelman
Director of Translational ScienceMedical Affairs Contact
Susan Demo
Vice President of Medical Affairs